Study details
Enrolling now
Cocoa Extract for Migraine Trial
Brigham and Women's Hospital
NCT IDNCT06808230ClinicalTrials.gov data as of Apr 2026
Target enrollment
114
Study length
about 1.4 years
Ages
18+
Locations
1 site in MA
What this study is about
This trial is testing if cocoa extract can help with migraines. Participants will take either cocoa extract or a placebo daily and provide urine samples and answer questionnaires.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Cocoa extract
- 2.Cocoa extract placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Dermatological Agents (Immunologic Factor Interactions)
Endpoints
Primary: Adherence, Recruitment, Retention
Secondary: Adverse events, Allodynia Symptom Checklist, PROMIS-29, Reports of worsening of migraine symptoms
Body systems
Neurology